Cantor Fitzgerald Initiates Coverage On Dyne Therapeutics with Overweight Rating
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsInitiation
Cantor Fitzgerald analyst Eric Schmidt initiates coverage on Dyne Therapeutics (NASDAQ:DYN) with a Overweight rating.
Cantor Fitzgerald analyst Eric Schmidt initiates coverage on Dyne Therapeutics (NASDAQ:DYN) with a Overweight rating.